Tarceva and T-lymphocyte count abnormal - from FDA reports

There is no T-lymphocyte count abnormal reported by people who take Tarceva yet. This review analyzes which people have T-lymphocyte count abnormal with Tarceva. It is created by eHealthMe based on reports from FDA, and is updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).

On Oct, 15, 2018

No report is found.

Do you have T-lymphocyte count abnormal while taking Tarceva?

You are not alone:

Related studies


Tarceva has active ingredients of erlotinib hydrochloride. It is often used in lung cancer. (latest outcomes from Tarceva 28,756 users)

T-lymphocyte Count Abnormal

T-lymphocyte count abnormal has been reported by people with multiple sclerosis, limb discomfort, osteoporosis (latest reports from 45 T-lymphocyte count abnormal patients).

Drugs that are associated with T-lymphocyte count abnormal
T-lymphocyte count abnormal
Could your condition cause T-lymphocyte count abnormal
T-lymphocyte count abnormal
Tarceva side effects
Browse all side effects of Tarceva
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Tarceva and have T-lymphocyte count abnormal

Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.